Press Release

Drugs Of Abuse Testing Market To Witness High Growth; Launch Of Strata®-X-Drug B Plus Will Propel Growth

Drugs of Abuse Testing Market Is Predicted to Grow Due To The Rising Investments in Novel Drugs By Key Players, says Fortune Business Insights

Rising investment in developing novel products by market players for drug abuse is a factor driving the global drugs of abuse testing market, says Fortune Business Insights in a report, titled “Drugs Of Abuse Testing Market Size, Share and Global Trend By Product (Equipment, Consumables), By Sample Type (Saliva, Urine, Hair, Breath, Blood, Sweat), By Application (Medical Screening, Monitoring Pain Management, Forensic & Legal Information, Employment Drug Testing, Sports & Athletics Testing), By End User (Hospital, Forensic Labs, Diagnostic Centres, Speciality Clinics) and Geography Forecast till 2026.” The growing trend of employing medical screening for drug abuse is contributing growth to the global drugs of abuse testing market.


Some of the major companies that are present in the global drugs of abuse testing market areDrugs Of Abuse Testing Market

  • Siemens Healthcare GmbH,
  • Abbott,
  • Thermo Fisher Scientific Inc.,
  • LifeSign LLC.,
  • MP Biomedicals,
  • Premier Biotech, Inc.,
  • MEDACX Ltd.,
  • Chromsystems Instruments & Chemicals GmbH,
  • AccuBioTech Co. Ltd.,
  • Screen Italia Srl,
  • Paramedical s.r.l.

Get PDF Brochure of this [email protected]

Launch Of Strata®-X-Drug B Plus Will Encourage Growth

Phenomenex Inc., a global leader of innovative technologies unveiled Strata®-X-Drug B Plus. The new drug is a solid phase extraction (SPE)  and can be used for urine drug testing in clinical and forensic toxicology labs. Strata®-X-Drug B Plus is predicted to witness high demand, stoked by the rising demand drug abuse test kit. Phenomenex’s Solvent Shielding Technology™enzyme hydrolysis to be passed out directly in the microplate well. Thus, helping in reducing time requirements, transfer steps and cost. This factor is likely to promote the drugs of abuse testing growth. Furthermore, the approval from the FDA for testing device by key players is also adding growth to the global drugs of abuse testing revenue. For instance, the FDA granted 510 (k) approval to OralTox, a rapid oral fluid testing device manufactured by Premier Biotech, Inc. for testing of 8 different drugs.


By Product

  • Equipment
  • Immunoassay Analyzers
  • Chromatography Instruments
  • Breath Analyzers
  • Consumables
  • Rapid Test Kits
  • Reagents
  • Others

By Sample Type

  • Saliva
  • Urine
  • Hair
  • Breath
  • Blood
  • Sweat

By Application

  • Medical Screening
  • Monitoring Pain Management
  • Forensic & Legal Information
  • Employment Drug Testing
  • Sports & Athletics Testing

By End-User

  • Hospital
  • Forensic Labs
  • Diagnostic Centres
  • Speciality Clinics
  • Others

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

More Trending Topics From Fortune Business [email protected]

Diabetes Monitoring Devices Market to Expand at 5.4% CAGR | USD 32,881.9 Mn by 2026

Immunodiagnostics Market Set for Rapid Growth | Trend & Demands 2026


Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *